Evidence map›Paper›PMID 33989118›Full record

ArticleHuman vaccines & immunotherapeutics2021

Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.

Imane Jroundi, Mohammed Benazzouz, Abdel Hakim Yahyane, Moulay Tahar Alaoui, Nathalie El Omeiri

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Imane JroundiUnit of Training and Research in Public Health and Social Accountability, School of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.ORCID 0000-0002-5380-6046
Mohammed BenazzouzNational Immunization Program Office, National Immunization Technical Advisory Group Secretary, Directory of Population, Ministry of Health, Rabat, Morocco.ORCID 0000-0001-8653-1985
Abdel Hakim YahyaneNational Immunization Program Office, National Immunization Technical Advisory Group Secretary, Directory of Population, Ministry of Health, Rabat, Morocco.ORCID 0000-0002-3082-4591
Moulay Tahar AlaouiNational Immunization Technical Advisory Group President, Rabat, Morocco.ORCID 0000-0002-0542-6129
Nathalie El OmeiriComprehensive Family Immunization Unit, Department of Family, Health Promotion and Life Course, Pan American Health Organization, Washington, DC, USA.ORCID 0000-0002-4412-7287

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main mission of a National Immunization Technical Advisory Group (NITAG) is to provide impartial, evidence-based recommendations on immunization to the Ministry of Health. We report on the findings from an evaluation of the Moroccan NITAG with emphasis on its functionality, quality of work processes and outputs, and its integration into the immunization policy process. We conducted a cross-sectional study from October to December 2019. We used the standardized, US-CDC/WHO-developed "simplified assessment tool for national immunization technical advisory groups". The evaluation included eight participants. The evaluation has shown that it fully complies with the WHO recommendations. Among its strengths, the Moroccan NITAG has a solid legal basis, diverse expertise and many years of combined experience. This composition contributed to the credibility and strength of its recommendations and facilitated their implementation. The NITAG could, however, benefit from implementing written declarations of interests and standardized operating procedures in addition to establishing a standardized methodology to guide and document the decision-making process. The Moroccan NITAG could also gain from inviting members with public health/epidemiology research experience and from exchanging with other NITAGs in the region and globally. Finally, ensuring sustainable funding for the NITAG's activities will be crucial, so that it can continue its valuable support to the national immunization program.

Indexed as

Advisory CommitteesHealth PolicyCross-Sectional StudiesHumansImmunizationImmunization Programsdecision makingevidence based decisionsNational Immunization technical advisory Group

Identifiers

PMID33989118
PMCPMC8475612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.